News
Your source for the latest updates, breakthroughs, and insights in drug development and manufacturing. Explore our featured stories, press releases, and event announcements to stay informed about our innovations and contributions to drug development and manufacturing advancements.
Verve Therapeutics Reports Promising Results for PCSK9 Gene Editing in HeFH
Verve Therapeutics’ VERVE-102 shows early success in lowering LDL cholesterol by 55% with a single dose, offering a potential one-time gene editing treatment for familial hypercholesterolemia...
MIT Engineers Develop Gene Circuit for Precise Control of Gene Therapy
MIT engineers have developed a gene circuit that precisely controls gene expression, offering potential breakthroughs in gene therapy for disorders like fragile X syndrome. This advancement helps ensure therapeutic genes are expressed at optimal levels, minimizing risks and paving the way for more effective treatments...
May 13-17 – American Society of Gene & Cell Therapy (ASGCT) Annual Meeting – 2025
Avance Biosciences is excited to exhibit at the ASGCT 2025 conference in New Orleans, LA, from May 13–17, 2025. Join us to explore our expert bioanalytical solutions for gene and cell therapy development. Visit booth #750 to learn how we can support your therapeutic advancements...
May 4-7 – American Assoc. of Pharmaceutical Scientists (AAPS) National Biotechnology Conference – 2025
Avance Biosciences™ is joining the 2025 AAPS National Biotechnology Conference to showcase our expertise in biological assay development, validation, and sample testing. Visit our booth to learn more about our innovative solutions and explore potential collaborations in drug development...
Imiquimod Shows Promise as Immune Enhancer in DNA-Based HIV Vaccine Study
A new preclinical study shows that Imiquimod enhances immune responses to an HIV DNA vaccine, offering promising implications for nucleic acid vaccine design and innate immune modulation strategies...
April 21-24 – World Vaccine Congress – 2025
Avance Biosciences is excited to participate in the World Vaccine Congress 2025, showcasing our advanced solutions in vaccine development, bioanalytics, and regulatory compliance. Join us to explore collaboration opportunities and learn how our services can support your vaccine research and clinical trials...